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A case of suspected delirious mania treated with benzodiazepines
Hala Katato, D.O., Mohan Gautam D.O., M.S., Esther Akinyemi, M.D.
Henry Ford Health System, Detroit, Michigan
Introduction
• Delirious mania is a life threatening syndrome characterized
by rapid onset of delirium, mania, psychosis and catatonia
• It is unexplained by other primary psychiatric and medical
illnesses
• It responds poorly, and can even be fatal, with traditional
pharmacotherapy management for delirium or mania such as
haloperidol and valproic acid, respectively
• Benzodiazepines are known to exacerbate symptoms of
delirium, however, they are uniquely beneficial in cases of
delirious mania
• If detected early and properly treated with high dose
benzodiazepines (or ECT if available), patients can avoid
prolonged hospital stays and consequential medical illnesses

• She was then started on valproic acid and haloperidol,
however, at reevaluation, she decompensated
• She had worsening of her paranoia, as well as catatonic
symptoms including posturing, echolalia and negativism
• The restraints in addition to the decompensation of the
patient’s clinical picture eventually led to the patient
developing a bilateral PE
• At this time we began to consider delirious mania as the
patient’s diagnosis and subsequently discontinued valproic
acid and haloperidol
• High dose lorazepam (2 mg TID) was utilized as monotherapy
which led to gradual resolution of her symptoms

Workup

• She demonstrated acute onset of disorganized thought and
behavior, inappropriate toileting, insomnia, paranoid
delusions, psychomotor agitation and pressured speech
• She clinically declined post administration of haloperidol and
valproic acid—medications that would typically improve
symptoms of delirium and mania, respectively
• Antipsychotics can exacerbate the symptoms of delirious
mania3
• This patient’s clinical decline caused her to be at risk to
herself by running into the street, and at risk to others by
becoming violent towards staff. She eventually required sitter
and restraints causing prolonged immobility, and inevitably,
bilateral PE.
• After we discontinued haloperidol and valproic acid and
treatment became solely lorazepam, her symptoms improved

Table 1: Medical Workup

4

Case
• We present the case of a 71-year-old African American female
with no past medical or psychiatric history who presented
hyper-verbal, hyperactive, decreased need for sleep and
paranoid about intruders breaking into her home
• She was found to have a UTI, which was treated, and she was
discharged. However, she presented to the hospital again for
worsening psychiatric symptoms which lead to her running
into the street due to the paranoia.
• An extensive medical workup was completed and was
unrevealing. See table 1.
• She demonstrated severe behavioral symptoms including
fluctuating orientation, pressured speech, insomnia,
hyperactivity, grandiosity, inappropriate toileting, and
paranoid delusions
• The patient was given low dose lorazepam and haloperidol,
however, she became violent towards staff, requiring restraints

BMP

Only abnormality was Low K at 2.7 which
was replaced

Folate (ng/mL)

6.7 (normal)

CBC

WBC 10.1, RBC 4.19, Hb 13.2, Hematocrit
38.7, MCV 95.3, Plt 168 (all normal)

Lead (ug/dL)

<1.0 (normal)

UA

Negative for nitrite, leukocyte esterase,
TSH
urobilinogen, glucose, bacteria. Small trace of (uIU/mL)
blood

2.84 (normal)

Urine Toxicology

Nonreactive

CXR

Negative for all including amphetamines,
Syphillis Serology
barbiturates, benzodiazepines, cannabinoids, (Treponemal IgG/IgM)
cocaine, ethanol, methadone, opiates,
phencyclidine and tricyclics
No acute process
Hepatitis and Liver Studies

CTH

No acute intracranial abnormality

MRI BRAIN

B12 (pg/mL)

No acute ischemia, mass lesion or abnormal
enhancement
328 (normal)

Negative

Microbiology including urine No growth/ nonreactive
culture, blood culture and
HIV Antigen/Antibody
Combo
ANA
Negative

Paraneoplastic Panel

No informative
antibodies detected

Discussion
• Benzodiazepines are contraindicated for most cases of
delirium. However, they are beneficial in cases of delirious
mania and catatonia.
• Some authors suggest delirious mania is actually a subset of
catatonia, as evidenced by their similar therapeutic response
to high dose benzodiazepines2
• It is known that UTIs can induce delirium in the elderly,
however, this patient’s symptoms surpassed just fluctuating
attention and orientation and rather met distinctive and severe
symptoms for delirious mania1

Conclusion
• Delirious mania is a deadly syndrome if not detected early
and treated appropriately with high dose benzodiazepines
• There should be a low threshold for diagnosis of this
syndrome if the patient meets criteria and does not respond to
traditional pharmacotherapies for delirium and mania such as
haloperidol and valproic acid, respectively
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